
CAR-T & Cellular Therapy Focus
Welcome to CAR-T & Cellular Therapy Focus, where you can explore the latest updates in this field by haematological disease and therapy type, showcasing expert interviews and discussions, podcasts and e-learning.
CAR-T and other cellular therapies are at the frontier of hematological malignancy research, offering the potential for paradigm-changing new treatments. Although various questions remain open, it is essential that healthcare professionals understand these therapies, including recognizing and managing their toxicities, and when and how to use them.
View all videosThe CAR-T & Cellular Therapy Focus on VJHemOnc is supported by Janssen Pharmaceuticals (a Johnson & Johnson Company) and Legend Biotech.
These supporters have no influence over the production of the content.
These supporters have no influence over the production of the content.
If you are interested in becoming a supporter of The CAR-T & Cellular Therapy Focus, please contact us

Latest CAR-T and Cellular Therapy Videos
View all videosView CAR-T and Cellular Therapy Videos by Disease Area
Multiple Myeloma
Lymphoma
ALL
AML
CLL
View CAR-T and Cellular Therapy Videos by Topic
Nursing
Clinical Practice
Policy
Treatment
Toxicity
Manufacturing
View CAR-T and Cellular Therapy Videos by Therapy Type
CAR T-Cell Therapy
NK-Cell Therapy
If you are interested in becoming a supporter of The CAR-T & Cellular Therapy Focus, please contact us